| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
1 Dept of Public Health, Division of Nutritional Epidemiology and 2 Laboratory of Pneumology, Catholic University of Leuven, Leuven, Belgium
CORRESPONDENCE: P.G.A. Van Hoydonck, Dept of Public Health, Division of Nutritional Epidemiology, Katholieke Universiteit Leuven, Kapucijnenvoer 33, 3000 Leuven, Belgium. Fax: 32 16336884. E-mail: Liesbeth.Temme@med.kuleuven.ac.be
Keywords: 8-isoprostane, exhaled breath condensate, healthy smokers, hydrogen peroxide, oxidative stress, reproducibility
Received: May 5, 2003
Accepted August 29, 2003
L.J. Dupont is supported by a postdoctoral research fellowship from the Fonds voor Wetenschappelijk Onderzoek – Vlaanderen (Fund for Scientific Research – Flanders, Brussels, Belgium).
ABSTRACT
Exhaled breath condensate (EBC) provides a noninvasive means of sampling the lower respiratory tract. Collection of EBC might be useful in the assessment of airway oxidative stress in smokers. The aim of this study was to determine 8-isoprostane and hydrogen peroxide levels in EBC, and, in addition, to investigate the reproducibility of these measurements.
EBC samples were collected from 12 healthy male smokers at three time points within 1 week. 8-isoprostane and H2O2 were measured in nonconcentrated EBC using immunochemical and colorimetric assays, respectively.
8-isoprostane and H2O2 were detected in only 36 and 47% of all EBC samples, respectively. It was not possible to calculate the within-subject variation in a reliable manner since only three of the 12 smokers exhibited detectable 8-isoprostane concentrations on all three occasions (mean 4.6 pg·mL–1; range 3.9–7.7 pg·mL–1), whereas H2O2 could not be detected on all three occasions in any of the smokers. Spiking experiments revealed a recovery of 83.5–109.5% for 8-isoprostane and 69.9–129.0% for H2O2 in fresh EBC samples.
It was concluded that levels of 8-isoprostane and hydrogen peroxide cannot be reproducibly assessed in exhaled breath condensate from healthy smokers because of their low concentration and/or the lack of sensitivity of the available assays.
This article has been cited by other articles:
|
|
 |
|
  P. P. Rosias, C. M. Robroeks, A. Kester, G. J. den Hartog, W. K. Wodzig, G. T. Rijkers, L. J. Zimmermann, C. P. van Schayck, Q. Jobsis, and E. Dompeling Biomarker reproducibility in exhaled breath condensate collected with different condensers Eur. Respir. J., May 1, 2008; 31(5): 934 - 942. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
V. L. Kinnula, H. Ilumets, M. Myllarniemi, A. Sovijarvi, and P. Rytila 8-Isoprostane as a marker of oxidative stress in nonsymptomatic cigarette smokers and COPD Eur. Respir. J., January 1, 2007; 29(1): 51 - 55. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. P. Rosias, C. M. Robroeks, H. J. Niemarkt, A. D. Kester, J. H. Vernooy, J. Suykerbuyk, J. Teunissen, J. Heynens, H. J. Hendriks, Q. Jobsis, et al. Breath condenser coatings affect measurement of biomarkers in exhaled breath condensate Eur. Respir. J., November 1, 2006; 28(5): 1036 - 1041. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. R. Wewel, J. A. M. Crusius, U. Gatzemeier, M. Heckmayr, G. Becher, H. Magnussen, R. A. Jorres, and O. Holz Time course of exhaled hydrogen peroxide and nitric oxide during chemotherapy. Eur. Respir. J., May 1, 2006; 27(5): 1033 - 1039. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
I. Horvath, J. Hunt, P. J. Barnes, and On behalf of the ATS/ERS Task Force on Exhaled Bre Exhaled breath condensate: methodological recommendations and unresolved questions Eur. Respir. J., September 1, 2005; 26(3): 523 - 548. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S Battaglia, H den Hertog, M C Timmers, S P G Lazeroms, A M Vignola, K F Rabe, V Bellia, P S Hiemstra, and P J Sterk Small airways function and molecular markers in exhaled air in mild asthma Thorax, August 1, 2005; 60(8): 639 - 644. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
